Private credit’s economic troubles are causing political problems for the industry as regulators rethink some of their 'light touch' promises.
Fund managers must show they can deliver good health outcomes if they’re going to stop the spread of antitrust and corporate-practice-of-medicine ideas.
The states prove to be a battlefield for private equity’s future in healthcare, as antitrust and corporate-practice-of-medicine bills spread.
GPs’ marks feed into faster NAV setting – and they are subject to legal obligations and distributors’ oversight.
Regulators use Trump’s 'America First' order to make it easier for (friendly) foreigners to invest here, private funds are ‘gatekeepers, not bystanders’ in sanctions enforcement, litigation finance has permeated (and warped) the legal profession and Paul Weiss hires a new partner.
Jonathan Epstein has spent more than a decade pushing, pulling and pleading to allow retirement savers to invest in private funds. On the eve of a world-shaking rulemaking notice, he shares his thoughts on how we got here, and where we go next.
The acquisition enables iCapital to offer sponsors solutions covering both individual and institutional investors.
The SEC’s staff purge only looks like relief.
Industry insiders warn that finance chiefs who delay data inventories and vendor outreach risk running out of time to meet the SEC’s cybersecurity requirements.
AI ‘can, should, and will catalyze a transformation of the technology of investment management,’ Brian Daly says, and regulators want industry’s input on where to put the guardrails.